Regarding efficacy, pan-JAK inhibitors, rather than JAK1 selective inhibitors, may work more effectively, especially for cases with a UIP pattern, considering a predominant role of JAK2 in fibrosis of ILDs. This evidence concerns the gene JAK1 and idiopathic pulmonary fibrosis.